Breaking News Instant updates and real-time market news.

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:00
06/19/18
06/19
17:00
06/19/18
17:00

Starbucks says has reduced number of skews in stores

  • 19

    Jun

  • 22

    Jun

SBUX Starbucks
$57.43

0.22 (0.38%)

05/21/18
JPMS
05/21/18
NO CHANGE
Target $64
JPMS
Overweight
JPMorgan likes Starbucks' risk/reward at current share levels
In a research note titled "Far from Perfect, but Good Enough for Where Stock is," JPMorgan analyst John Ivankoe says he likes Starbucks' risk/reward profile at current share levels. Following the company's first ever in-country analyst day focused on China, the analyst believes "multiple downside is very limited." Downside risk in the stock comes from earnings, not multiple compression, Ivankoe tells investors. He keeps an Overweight rating on Starbucks with a $64 price target.
05/21/18
UBSW
05/21/18
NO CHANGE
Target $66
UBSW
Buy
Starbucks deserves a premium multiple, says UBS
UBS analyst Dennis Geiger said Starbucks has broad-based quality growth and as a results deserves its premium multiple. The analyst went to China and saw a strong and increasingly important growth opportunity. The analyst said new products, digital, and market tailwinds will help contribute to its positive same-store-sales growth. Geiger reiterated his Buy rating and $66 price target on Starbucks shares.
06/05/18
MSCO
06/05/18
NO CHANGE
Target $72
MSCO
Overweight
Schultz leaving a loss, but Morgan Stanley says change can benefit Starbucks too
Morgan Stanley John Glass said Howard Schultz stepping down from his role of executive chairman must be considered a loss for Starbucks, but he added that change can have some potential benefits as well. Glass contends Starbucks is at an important crossroads in its strategy and he believes this event perhaps could further accelerate this process as the new leadership team put the company on a path toward the future with their own ideas. Glass maintains his Overweight rating and $72 price target on Starbucks shares.
06/05/18
BARD
06/05/18
NO CHANGE
Target $65
BARD
Outperform
Starbucks loss of Schultz raises risk profile, says Baird
Baird analyst David Tarantino believes the departure of Howard Schultz from Starbucks raises the risk profile for investors. The analyst said he is disappointed to see such an iconic leader exit the business, but he is cautiously optimistic the current leadership team can execute the current strategies effectively. Tarantino lowered his price target to $65 from $68 on Starbucks shares, but maintains an Outperform rating.

TODAY'S FREE FLY STORIES

TPC

Tutor Perini

$17.72

0.25 (1.43%)

06:25
02/21/19
02/21
06:25
02/21/19
06:25
Hot Stocks
Tutor Perini awarded $253M contract by MTA New York City Transit »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

STNG

Scorpio Tankers

$19.66

-0.28 (-1.40%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Conference/Events
Scorpio Tankers management to meet with BTIG »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Hot Stocks
Dine Brands board approves 10% increase to quarterly dividend to 69c per share »

The company's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GMDA

Gamida Cell

$13.46

0.01 (0.07%)

06:23
02/21/19
02/21
06:23
02/21/19
06:23
Hot Stocks
Gamida Cell presents new data from NAM-NK and NiCord programs »

Gamida Cell announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Earnings
Dine Brands sees FY19 adjusted EPS $6.90-$7.20, consensus $6.93 »

Applebee's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LPCN

Lipocine

$1.71

(0.00%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Lipocine management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KURA

Kura Oncology

$15.06

-0.22 (-1.44%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Kura Oncology management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Earnings
Dine Brands reports Q4 adjusted EPS $1.70, consensus $1.57 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JSAIY

J Sainsbury

$0.00

(0.00%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Downgrade
J Sainsbury rating change  »

J Sainsbury downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$34.71

0.475 (1.39%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
Knight-Swift management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KIDS

OrthoPediatrics

$38.34

0.96 (2.57%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
OrthoPediatrics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Mar

  • 27

    Mar

GDOT

Green Dot

$74.69

-0.05 (-0.07%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Green Dot analyst commentary  »

Green Dot Q4 margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$97.13

0.18 (0.19%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Grand Canyon analyst commentary  »

Grand Canyon correction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$89.52

1.55 (1.76%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Conference/Events
Kadant management to meet with Barrington »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SCBFF

Standard Chartered

$0.00

(0.00%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Periodicals
Standard Chartered earmarks $900M for U.S., UK fines, FT reports »

Standard Chartered has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
Breaking Earnings news story on PQ Group »

PQ Group sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
PQ Group sees FY19 revenue $1.64B-$1.67B, consensus $1.68B »

Sees FY19: Adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Earnings
PQ Group reports Q4 adjusted EPS 17c, consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TEF

Telefonica

$8.73

0.07 (0.81%)

, TIGO

Millicom

$60.25

(0.00%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Hot Stocks
Millicom buys Telefonica mobile businesses in Central America for $1.65B »

Millicom International…

TEF

Telefonica

$8.73

0.07 (0.81%)

TIGO

Millicom

$60.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 12

    Mar

  • 19

    Mar

  • 19

    Mar

HTGC

Hercules Capital

$13.12

0.07 (0.54%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Hot Stocks
Hercules Capital names Seth Meyer as CFO »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JOUT

Johnson Outdoors

$65.68

-0.23 (-0.35%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Conference/Events
Johnson Outdoors management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 28

    Feb

  • 28

    Feb

CGC

Canopy Growth

$46.18

-0.2 (-0.43%)

06:14
02/21/19
02/21
06:14
02/21/19
06:14
Recommendations
Canopy Growth analyst commentary  »

Piper Jaffray remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAP

SAP

$106.91

0.08 (0.07%)

06:14
02/21/19
02/21
06:14
02/21/19
06:14
Hot Stocks
SAP board recommends FY18 dividend increase of 7% to EUR1.50 per share »

The supervisory board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

THRM

Gentherm

$42.86

-0.22 (-0.51%)

06:13
02/21/19
02/21
06:13
02/21/19
06:13
Earnings
Gentherm backs product revenue growth of high single-digit CAGR for 2018-2021 »

Based on 2018 results and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

THRM

Gentherm

$42.86

-0.22 (-0.51%)

06:11
02/21/19
02/21
06:11
02/21/19
06:11
Earnings
Gentherm sees FY19 product revenue $1.01B-$1.04B, consensus $1.1B »

Sees FY19: Operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.